Quarterly report · Q2
3583.TEDINET S100PIIF
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥341m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥366m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥366m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥727m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥363m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥405m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥365m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥270m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥537m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥252m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥270m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥252m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥9.4bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥9.4bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥9.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥190m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥649m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥44m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥189m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥47m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥114m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥266m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥21m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥97.39 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.08 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.04 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.19 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.71 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥344,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥4m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥696m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥693m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥44m |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥451m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥495m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥14m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥491m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥14m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥697m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥695m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| jpcrp040300-q2r_E00584-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥77m |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00584-000Technological Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥449m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥527m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥513m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Decrease increase in inventories ope cf | Prior1YTDDuration | 48179000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -212773000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 70951000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -15665000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | 60919000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | 36677000 | JPY |
| Decrease increase in other current assets ope cf | Prior1YTDDuration | 12042000 | JPY |
| Decrease increase in other current assets ope cf | CurrentYTDDuration | 757000 | JPY |
| Increase decrease in other current liabilities ope cf | Prior1YTDDuration | 11592000 | JPY |
| Increase decrease in other current liabilities ope cf | CurrentYTDDuration | -44813000 | JPY |
| Decrease increase in other noncurrent assets ope cf | Prior1YTDDuration | -1048000 | JPY |
| Decrease increase in other noncurrent assets ope cf | CurrentYTDDuration | -6013000 | JPY |
| Increase decrease in other noncurrent liabilities ope cf | Prior1YTDDuration | 1483000 | JPY |
| Increase decrease in other noncurrent liabilities ope cf | CurrentYTDDuration | -0 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 752414000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 348486000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1724000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 2501000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -7576000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -6694000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -97225000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -154128000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 649337000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 190164000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -12000000 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -12001000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -35685000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -143674000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 2267000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 106817000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -2121000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1967000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -627000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -652000 | JPY |
| Purchase of insurance funds inv cf | Prior1YTDDuration | -1771000 | JPY |
| Purchase of insurance funds inv cf | CurrentYTDDuration | -1518000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | 7983000 | JPY |
| Collection of lease deposits inv cf | Prior1YTDDuration | 148000 | JPY |
| Collection of lease deposits inv cf | CurrentYTDDuration | － | JPY |
| Decrease increase in other investments inv cf | Prior1YTDDuration | 2652000 | JPY |
| Decrease increase in other investments inv cf | CurrentYTDDuration | 985000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -47140000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -44026000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 250000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 200000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -204868000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -222258000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -46197000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -76732000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |